Get Premium to unlock powerful stock data

Novo Holdings A Buys Boston Scientific Corp, VectivBio Holding AG, Rocket Pharmaceuticals Inc, Sells Inogen Inc, Harmony Biosciences Holdings Inc, Morphic Holding Inc

Author's Avatar
insider
Nov 15, 2021
Article's Main Image
Investment company Novo Holdings A (Current Portfolio) buys Boston Scientific Corp, VectivBio Holding AG, Rocket Pharmaceuticals Inc, Amicus Therapeutics Inc, Pharvaris NV, sells Inogen Inc, Harmony Biosciences Holdings Inc, Morphic Holding Inc, Inozyme Pharma Inc, Protagonist Therapeutics Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Novo Holdings A. As of 2021Q3, Novo Holdings A owns 49 stocks with a total value of $1.9 billion. These are the details of the buys and sells.

For the details of Novo Holdings A's stock buys and sells, go to https://www.gurufocus.com/guru/novo+holdings+a/current-portfolio/portfolio

These are the top 5 holdings of Novo Holdings A
  1. Vanguard Total Stock Market ETF (VTI) - 1,933,900 shares, 22.21% of the total portfolio.
  2. Brookfield Asset Management Inc (BAM) - 3,093,171 shares, 8.56% of the total portfolio. Shares added by 0.59%
  3. Boston Scientific Corp (BSX) - 3,463,577 shares, 7.77% of the total portfolio. New Position
  4. Apple Inc (AAPL) - 1,037,404 shares, 7.59% of the total portfolio.
  5. Morphic Holding Inc (MORF) - 2,050,446 shares, 6.01% of the total portfolio. Shares reduced by 22.49%
New Purchase: Boston Scientific Corp (BSX)

Novo Holdings A initiated holding in Boston Scientific Corp. The purchase prices were between $41.23 and $45.88, with an estimated average price of $44.25. The stock is now traded at around $41.610000. The impact to a portfolio due to this purchase was 7.77%. The holding were 3,463,577 shares as of 2021-09-30.

New Purchase: VectivBio Holding AG (VECT)

Novo Holdings A initiated holding in VectivBio Holding AG. The purchase prices were between $6.7 and $11.54, with an estimated average price of $8.6. The stock is now traded at around $4.850000. The impact to a portfolio due to this purchase was 1.41%. The holding were 3,522,019 shares as of 2021-09-30.

New Purchase: Rocket Pharmaceuticals Inc (RCKT)

Novo Holdings A initiated holding in Rocket Pharmaceuticals Inc. The purchase prices were between $27.42 and $48.97, with an estimated average price of $36.54. The stock is now traded at around $27.495000. The impact to a portfolio due to this purchase was 0.83%. The holding were 534,085 shares as of 2021-09-30.

New Purchase: Annexon Inc (ANNX)

Novo Holdings A initiated holding in Annexon Inc. The purchase prices were between $16.35 and $23.4, with an estimated average price of $20.28. The stock is now traded at around $15.460000. The impact to a portfolio due to this purchase was 0.11%. The holding were 114,330 shares as of 2021-09-30.

Added: Pharvaris NV (PHVS)

Novo Holdings A added to a holding in Pharvaris NV by 276.94%. The purchase prices were between $13.14 and $20.97, with an estimated average price of $17.13. The stock is now traded at around $15.750000. The impact to a portfolio due to this purchase was 0.28%. The holding were 418,943 shares as of 2021-09-30.

Added: Amicus Therapeutics Inc (FOLD)

Novo Holdings A added to a holding in Amicus Therapeutics Inc by 28.15%. The purchase prices were between $8.74 and $11.84, with an estimated average price of $10.24. The stock is now traded at around $12.000000. The impact to a portfolio due to this purchase was 0.28%. The holding were 2,560,211 shares as of 2021-09-30.

Added: Kinnate Biopharma Inc (KNTE)

Novo Holdings A added to a holding in Kinnate Biopharma Inc by 66.18%. The purchase prices were between $17.81 and $24.87, with an estimated average price of $21.83. The stock is now traded at around $22.450000. The impact to a portfolio due to this purchase was 0.23%. The holding were 498,528 shares as of 2021-09-30.

Added: Iovance Biotherapeutics Inc (IOVA)

Novo Holdings A added to a holding in Iovance Biotherapeutics Inc by 23.90%. The purchase prices were between $20.35 and $26.63, with an estimated average price of $23.63. The stock is now traded at around $19.580000. The impact to a portfolio due to this purchase was 0.21%. The holding were 836,518 shares as of 2021-09-30.

Added: Akouos Inc (AKUS)

Novo Holdings A added to a holding in Akouos Inc by 55.01%. The purchase prices were between $9.93 and $13.59, with an estimated average price of $12.01. The stock is now traded at around $9.040000. The impact to a portfolio due to this purchase was 0.15%. The holding were 711,945 shares as of 2021-09-30.

Added: Pulmonx Corp (LUNG)

Novo Holdings A added to a holding in Pulmonx Corp by 32.08%. The purchase prices were between $35.98 and $44.48, with an estimated average price of $39.46. The stock is now traded at around $39.855000. The impact to a portfolio due to this purchase was 0.11%. The holding were 247,047 shares as of 2021-09-30.

Sold Out: Inozyme Pharma Inc (INZY)

Novo Holdings A sold out a holding in Inozyme Pharma Inc. The sale prices were between $11.12 and $19.4, with an estimated average price of $15.62.

Sold Out: Protagonist Therapeutics Inc (PTGX)

Novo Holdings A sold out a holding in Protagonist Therapeutics Inc. The sale prices were between $12.95 and $49.69, with an estimated average price of $42.78.

Sold Out: Legend Biotech Corp (LEGN)

Novo Holdings A sold out a holding in Legend Biotech Corp. The sale prices were between $35.31 and $50.56, with an estimated average price of $41.56.

Sold Out: Eargo Inc (EAR)

Novo Holdings A sold out a holding in Eargo Inc. The sale prices were between $6.59 and $38.71, with an estimated average price of $26.78.

Sold Out: AbCellera Biologics Inc (ABCL)

Novo Holdings A sold out a holding in AbCellera Biologics Inc. The sale prices were between $14.85 and $21.34, with an estimated average price of $17.74.

Sold Out: Intersect ENT Inc (XENT)

Novo Holdings A sold out a holding in Intersect ENT Inc. The sale prices were between $18.11 and $28.01, with an estimated average price of $24.68.



Here is the complete portfolio of Novo Holdings A. Also check out:

1. Novo Holdings A's Undervalued Stocks
2. Novo Holdings A's Top Growth Companies, and
3. Novo Holdings A's High Yield stocks
4. Stocks that Novo Holdings A keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus